Cardioprotective growth factors
- 13 February 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 83 (2) , 179-194
Abstract
Many of the originally identified cardiovascular ‘growth factors’ have been demonstrated to exert a diverse variety of actions within the cardiovascular system, the majority of which are unrelated to their initially proposed mechanism of action. Interestingly, several of these growth factors have been demonstrated to protect the cardiomyocyte from the detrimental effects of acute ischaemia–reperfusion injury, through the activation of a variety of cell-surface receptors and the subsequent recruitment of a number of intracellular signal transduction pathways, which include components of the reperfusion injury salvage kinase pathway. This article will review several of these cardioprotective growth factors with respect to their ability to confer direct myocardial protection, focusing on the underlying signalling pathways involved and their potential for clinical application.Keywords
This publication has 175 references indexed in Scilit:
- Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusionBasic Research in Cardiology, 2008
- Insulin signaling pathways and cardiac growthJournal of Molecular and Cellular Cardiology, 2008
- Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and Therapeutic Efficacy for Myocardial InfarctionJACC, 2008
- Fibroblast growth factor-2 and cardioprotectionHeart Failure Reviews, 2007
- VEGFR1 (Flt-1+/−) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardiumFree Radical Biology and Medicine, 2007
- The lack of cardiotrophin-1 alters expression of interleukin-6 and leukemia inhibitory factor mRNA but does not impair cardiac injury responseCytokine, 2006
- Survival kinases in ischemic preconditioning and postconditioningCardiovascular Research, 2006
- The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and diseaseJournal of Molecular and Cellular Cardiology, 2004
- The Heart Is a Source of Circulating Cardiotrophin-1 in HumansBiochemical and Biophysical Research Communications, 2000
- An Immunoluminometric Assay for Cardiotrophin-1: A Newly Identified Cytokine Is Present in Normal Human Plasma and Is Increased in Heart FailureBiochemical and Biophysical Research Communications, 1999